Journal Papers, Abstracts, and Commentaries
|
| |
Prognostic value of viral eradication for major adverse
cardiovascular events in hepatitis C cirrhotic patients.
Cacoub P, Nahon P, Layese R, Blaise L, et al
Am Heart J.
2018 Apr;198:4-17
Abstract
Chronic hepatitis C virus infection: a new modifiable cardio-metabolic risk
factor?
Cuciureanu T, Chiriac S, Chiorescu M,
et al
Clujul Med.
2017;90(3):251-255
Abstract
Cardiovascular Manifestations of Hepatitis C Virus.
Goossens N, Negro F.
Clin
Liver Dis. 2017 Aug;21(3):465-473.
d
Abstract
Non-neoplastic Portal Vein Thrombosis in HCV Cirrhosis Patients: Is it an Immuno-Inflammatory
Disorder?
A Abu El-Makarem M, F El-Akad A, M Elian M,
Ann Hepatol.
2017 Aug 1;16(4):574-583.
Abstract
High
incidence of cardiac dysfunction and response to antiviral treatment in patients
with chronic hepatitis C virus infection
Poller W, Kaya Z, Muche M, et al
Clin Res Cardiol. 2017
Feb 24.
Abstract
Preclinical Assessment of the Clinical Cardiac Drug-Drug Interaction Associated
with the Combination of HCV-NI Antivirals and Amiodarone.
Regan CP, Morissette P, Regan HK,
et al
Hepatology.
2016 Jul 30.
Abstract
Sustained virologic response to interferon-free therapies ameliorates
HCV-induced portal hypertension.
Mandorfer M, Kozbial K, Schwabl P,
et al
J
Hepatol. 2016 May 27.
Abstract
Chronic hepatitis C virus infection, a new cardiovascular risk factor?
Domont F, Cacoub P.
Liver Int. 2016 Jan
13.
Abstract
Associations of chronic hepatitis C with
metabolic and cardiac outcomes.
Younossi ZM, Stepanova M, Nader F,
et al
Aliment Pharmacol Ther.
2013 Feb 5.
Abstract |
Risk of cardiovascular disease in HIV,
hepatitis C, or HIV/hepatitis C patients compared to the
general population.
Kakinami L, Block RC, Adams MJ, et al
Int J Clin Pract.
2013 Jan;67(1):6-13.
Abstract
Hepatitis C virus infection and risk of
coronary artery disease: a systematic review of the
literature.
Roed T, Lebech AM, Kjaer A, Weis N.
Clin Physiol Funct Imaging. 2012 Nov;32(6):421-30
Abstract
Myocardial injury in patients with chronic
hepatitis C infection.
Maruyama S, Koda M, Oyake N, et al
J Hepatol.
2012 Aug 10.
Abstract
Effects of Hepatitis C virus on cardiovascular risk
in infected patients: A comparative study.
Oliveira CP, Kappel CR, Siqueira ER,
et al
Int J Cardiol.
2011 Jul 22.
Abstract |
|
|
|
Journal Papers, Abstracts, and Commentaries |
| |
| |
Hepatitis C virus and atherosclerosis: A legacy after virologic cure?
Bassendine MF, Nielsen SU, Bridge SH,
Clin Res Hepatol Gastroenterol.
2016 Nov 10.
Abstract
Hepatitis C and risk of coronary atherosclerosis - A systematic review.
Olubamwo OO, Aregbesola AO, Miettola J,
et al
Public Health. 2016 May
17.
Abstract
Chronic Hepatitis C Virus Infection Is Associated with Subclinical Coronary
Atherosclerosis in the Multicenter AIDS Cohort Study (MACS): a
Cross-Sectional Study.
McKibben RA, Haberlen SA, Post WS,
et al
J Infect Dis. 2015 Jul
27
Abstract
Insulin-resistance HCV infection-related affects vascular stiffness in
normotensives.
Perticone M, Maio R, Tassone EJ, et al
Atherosclerosis. 2014 Nov
29;238(1):108-112.
Abstract
FULL-TEXT ARTICLE
Is hepatitis C associated with atherosclerotic burden? A systematic review
and meta-analysis.
Huang H, Kang R, Zhao Z.
PLoS One. 2014 Sep 3;9(9):e106376.
Paper
FULL-TEXT ARTICLE
Chronic
hepatitis C virus infection and atherosclerosis: Clinical impact and
mechanisms.
Adinolfi LE, Zampino R, Restivo L, et
al
World J Gastroenterol.
2014 Apr 7;20(13):3410-3417
Paper
Chronic HCV infection is a risk of atherosclerosis.
Role of HCV and HCV-related steatosis.
Adinolfi LE, Restivo L, Zampino R,
et al
Atherosclerosis.
2012 Feb
Abstract |
Hepatitis C infection and clearance: impact
on atherosclerosis and cardiometabolic
risk factors.
Mostafa A, Mohamed MK, Saeed M, et al
Gut.
2010 Jun 28
Abstract |
The Effects of Recombinant Human Leptin on Visceral Fat, Dyslipidemia, and
Insulin Resistance
in Patients with HIV-Associated Lipoatrophy and Hypoleptinemia.
Mulligan K, Khatami H, Schwarz JM, et
al
J Clin Endocrinol Metab. 2009 Jan
27.
Abstract |
Metabolic disorders and chronic HIV and HCV infection.
Slama L, Le Camus C, Serfaty L, et al
Diabetes Metab. 2008
Nov 27.
Abstract |
|
General
Reports
HCV
Extrahepatic Disorders
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader